JONATHAN ZIRNA: Open Payments
NPI 1417485871 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 33 payments from 14 companies in 2025. Trend: 2023 $601 · 2024 $350 · 2025 $660
Food & beverage: $660
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 6 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $114 |
| E.R. Squibb & Sons, L.L.C. | 5 | $80 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| Merck Sharp & Dohme LLC | 2 | $52 |
| ABIOMED | 1 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Edwards Lifesciences Corporation | 1 | $32 |
| Impulse Dynamics (USA) Inc. | 1 | $27 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $24 |
Products named: ONPATTRO, JARDIANCE, CAMZYOS, LEQVIO, VERQUVO, WAINUA, Optimizer, LifeVest.
Industry payments across NY — which companies pay providers there.
